Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,775 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations.
Matsuda K, Shimada A, Yoshida N, Ogawa A, Watanabe A, Yajima S, Iizuka S, Koike K, Yanai F, Kawasaki K, Yanagimachi M, Kikuchi A, Ohtsuka Y, Hidaka E, Yamauchi K, Tanaka M, Yanagisawa R, Nakazawa Y, Shiohara M, Manabe A, Kojima S, Koike K. Matsuda K, et al. Among authors: watanabe a. Blood. 2007 Jun 15;109(12):5477-80. doi: 10.1182/blood-2006-09-046649. Epub 2007 Mar 1. Blood. 2007. PMID: 17332249 Free article.
Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
Muramatsu H, Kojima S, Yoshimi A, Atsuta Y, Kato K, Nagatoshi Y, Inoue M, Koike K, Kawase T, Ito M, Kurosawa H, Tanizawa A, Tono C, Hamamoto K, Hotta N, Watanabe A, Morishima Y, Kawa K, Shimada H. Muramatsu H, et al. Among authors: watanabe a. Biol Blood Marrow Transplant. 2010 Feb;16(2):231-8. doi: 10.1016/j.bbmt.2009.09.022. Epub 2009 Sep 30. Biol Blood Marrow Transplant. 2010. PMID: 19800016 Free article.
Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia.
Matsuda K, Sakashita K, Taira C, Tanaka-Yanagisawa M, Yanagisawa R, Shiohara M, Kanegane H, Hasegawa D, Kawasaki K, Endo M, Yajima S, Sasaki S, Kato K, Koike K, Kikuchi A, Ogawa A, Watanabe A, Sotomatsu M, Nonoyama S, Koike K. Matsuda K, et al. Among authors: watanabe a. Br J Haematol. 2010 Feb;148(4):593-9. doi: 10.1111/j.1365-2141.2009.07968.x. Epub 2009 Oct 29. Br J Haematol. 2010. PMID: 19874312 Free article.
Long-term haematological improvement after non-intensive or no chemotherapy in juvenile myelomonocytic leukaemia and poor correlation with adult myelodysplasia spliceosome-related mutations.
Matsuda K, Yoshida N, Miura S, Nakazawa Y, Sakashita K, Hyakuna N, Saito M, Kato F, Ogawa A, Watanabe A, Sotomatsu M, Kobayashi C, Ito T, Ishida F, Manabe A, Kojima S, Koike K. Matsuda K, et al. Among authors: watanabe a. Br J Haematol. 2012 Jun;157(5):647-50. doi: 10.1111/j.1365-2141.2012.09063.x. Epub 2012 Feb 20. Br J Haematol. 2012. PMID: 22348520 Free article. No abstract available.
Sequential use of second-generation tyrosine kinase inhibitors following imatinib therapy in pediatric chronic myeloid leukemia: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Kurosawa H, Tanizawa A, Muramatsu H, Tono C, Watanabe A, Shima H, Ito M, Yuza Y, Hamamoto K, Hotta N, Okada M, Saito AM, Manabe A, Mizutani S, Adachi S, Horibe K, Ishii E, Shimada H. Kurosawa H, et al. Among authors: watanabe a. Pediatr Blood Cancer. 2018 Dec;65(12):e27368. doi: 10.1002/pbc.27368. Epub 2018 Aug 7. Pediatr Blood Cancer. 2018. PMID: 30084127 Clinical Trial.
Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia.
Shima H, Kada A, Tanizawa A, Sato I, Tono C, Ito M, Yuza Y, Watanabe A, Kamibeppu K, Uryu H, Koh K, Imai C, Yoshida N, Koga Y, Fujita N, Saito AM, Adachi S, Ishii E, Shimada H. Shima H, et al. Among authors: watanabe a. Pediatr Blood Cancer. 2022 Aug;69(8):e29699. doi: 10.1002/pbc.29699. Epub 2022 Apr 11. Pediatr Blood Cancer. 2022. PMID: 35403816
4,775 results